WBA240802P12500
- 0.78
- -0.09-10.34%
Walgreens Boots Alliance Newsroom
Barclays Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7
Analysts Offer Insights on Healthcare Companies: R1 RCM (RCM) and Walgreens Boots Alliance (WBA)
HSBC Adjusts Price Target on Walgreens Boots Alliance to $7 From $11
Walgreens Boots Alliance Analyst Ratings
Barclays Adjusts Price Target on Walgreens Boots Alliance to $7 From $11
Baptista Research Upgrades Walgreens Boots Alliance to Outperform From Hold, Price Target Is $13.70
Walgreens Boots Alliance Analyst Ratings
Walgreens Boots Alliance (WBA) Receives a Hold From RBC Capital
RBC Cuts Price Target on Walgreens Boots Alliance to $13 From $22, Keeps Sector Perform Rating
JPMorgan Adjusts Price Target on Walgreens Boots Alliance to $20 From $30, Maintains Overweight Rating
Walgreens Boots Alliance Analyst Ratings
Morgan Stanley Lowers Price Target on Walgreens Boots Alliance to $9 From $13 Amid Guidance Cut, Keeps Underweight Rating
Nephron Research Cuts Walgreens Boots Alliance's Price Target to $13 From $24, Hold Rating Maintained
Evercore ISI Adjusts Price Target on Walgreens Boots Alliance to $10 From $17
Mizuho Securities Adjusts Price Target on Walgreens Boots Alliance to $19 From $23
Walgreens Boots Alliance Analyst Ratings
Walgreens Boots Alliance Analyst Ratings
Evercore ISI Adjusts Price Target on Walgreens Boots Alliance to $17 From $18, Keeps In Line Rating
Walgreens Boots Alliance Analyst Ratings
Walgreens Boots Alliance: A Sell Rating Amidst Retail Challenges and Generic Pricing Pressures